Riskpilot← Back to searchSign inGet full accessKAIBOSH NORGE AS
ASBankruptOrg 921864906Christian Michelsens Gate 1, 5012 BergenRetail sale of medical and orthopaedic goods · NACE 4774Est. 201819 employees
Revenue 2023
NOK 11,4M
+15% vs 2022
EBITDA margin
-22.6%
+18% vs 2022
Equity ratio
-119.7%
Financial strength
Net profit 2023
NOK -5M
-81% vs 2022
| Revenue | NOK 11,4M | +15% |
| EBITDA | NOK -2,6M | +18% |
| Net profit | NOK -5M | -81% |
| Total assets | NOK 4,7M | -29% |
| Equity | NOK -5,6M | -880% |
| Employees | 19 | — |
Legal name
KAIBOSH NORGE AS
Org number
921864906
Legal form
Aksjeselskap
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
11. desember 2018
Share capital
NOK 1 264 301
Employees
19 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Kjøp og salg av briller, solbriller og alt som hører naturlig til dette. Selskapet kan også investere i aksjer og selskapsandeler.
Address
Christian Michelsens Gate 1, 5012 Bergen
Phone
+4756123260
Email
hello@kaibosh.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 4 394 | 8 621 | 10 353 | 9 931 | 11 415 |
| Staff expenses | −1 654 | −4 128 | −4 526 | −5 390 | −6 335 |
| EBITDA | −2 446 | −1 685 | −877 | −3 147 | −2 575 |
| Depreciation & amort. | −32 | −86 | −121 | −102 | −180 |
| EBIT | −2 478 | −1 770 | −998 | −3 249 | −2 755 |
| Net financials | −24 | −104 | −124 | −262 | −343 |
| Profit before tax | −2 502 | −1 874 | −1 122 | −3 511 | −3 098 |
| Tax | −530 | −391 | −237 | −748 | 1 906 |
| Net profit | −1 972 | −1 483 | −885 | −2 763 | −5 004 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 2 777 | 4 394 | 4 558 | 6 598 | 4 655 |
| Equity | 128 | 289 | 194 | −569 | −5 573 |
| Long-term debt | 0 | 2 174 | 2 544 | 3 014 | 2 425 |
| Short-term debt | 2 648 | 1 930 | 1 820 | 4 153 | 7 803 |
| Total debt | 2 648 | 4 105 | 4 364 | 7 167 | 10 228 |
EBITDA margin
-22.6%
This company
15.8%
Market median
-243% vs market
20192023
Equity ratio
-119.7%
This company
38.2%
Market median
-413% vs market
20192023
Return on equity
-500444600.0%
This company
18.4%
Market median
-2719807709% vs market
20192023
Net profit margin
-43.8%
This company
8.1%
Market median
-641% vs market
20192023
Asset turnover
2.45×
This company
1.12×
Market median
+119% vs market
20192023
Debt / equity
1.84×
This company
0.62×
Market median
-197% vs market
20192023
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HF Chief Executive Officer | Chief Executive Officer | 2023 |
| Former (1) | ||
MR Chief Executive Officer | Chief Executive Officer | 2020 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2022 | |
| Former (1) | ||
| Board of Directors | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 44.89% | 44.89% | 2024 | |
| Company | 21.42% | 21.42% | 2024 | |
| Company | 7.26% | 7.26% | 2024 | |
| Company | 5.27% | 5.27% | 2024 | |
| Company | 5.07% | 5.07% | 2024 | |
| Company | 4.42% | 4.42% | 2022 | |
| Individual | 3.05% | 3.05% | 2024 | |
| Company | 2.66% | 2.66% | 2024 | |
| Company | 2.55% | 2.55% | 2024 | |
| Company | 1.53% | 1.53% | 2024 | |
| Company | 1.35% | 1.35% | 2024 | |
| Company | 1.19% | 1.19% | 2024 | |
| Company | 1.18% | 1.18% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Tom Jørgensen Holding As
KAIBOSH NORGE AS Board members of KAIBOSH NORGE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Michelle Rowley | Chief Executive Officer | 0 companies |
| Helge Flo | Chief Executive Officer | 0 companies |
| Ivar Borge | Chairman | 0 companies |
| Christer Rødland Vikebø | Board of Directors | 0 companies |